EKMAN LARS received a stock award from ULTRAGENYX PHARMACEUTICAL INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/28/2021ACC: 0001209191-21-043543
+6.27K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
6.27K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2.15K
Price / share
—
Trade value
—
% of position
17.4%
6/24/2021
12.30K→14.45K
Total
Net shares
+2.15K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/24/2021 | A · Award | +2.15K | — | — | 17.4% | 12.30K | 14.45K |
| Total | +2.15K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
4.13K shares
Shares
+4.13K
Strike price
93.20
Held after
4.13K
Exercisable
—
6/24/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock4.13K shares | 6/24/2021 | A · Award | +4.13K | 93.20 | — | 4.13K |